Hokko Chemical Industry Co., Ltd.

4992.T
Agricultural Inputs
2026/01/16 Updated
Market Cap: $282.9M (¥44.8B)
Stock Price: $10.97 (¥1,739)
Exchange Rate: 1 USD = ¥158.48

Notice Regarding Revisions to Consolidated Performance Targets in the Long-Term Management Plan and the Second Three-Year Management Plan

Hokko Chemical Industry revised the consolidated performance targets in its long-term management plan and the second three-year management plan, raising the fiscal 2029 sales target to ¥55 billion (+¥3 billion) and ordinary income to ¥6.8 billion plus α (+¥0.8 billion plus α).

Importance:
Page Updated: January 13, 2026
IR Disclosure Date: January 13, 2026

Key Figures

  • Fiscal 2029 Sales Target: ¥55 billion (before revision ¥52 billion)
  • Fiscal 2029 Ordinary Income Target: ¥6.8 billion plus α (before revision ¥6.0 billion)
  • Fiscal 2026 Sales Target: ¥52 billion (before revision ¥48.8 billion)

AI要約

Details of Performance Target Revisions

At the board of directors meeting held on January 13, 2026, Hokko Chemical Industry Co., Ltd. revised the consolidated performance targets of the Long-Term Management Plan (FY2021–FY2029) and the Second Three-Year Management Plan (FY2024–FY2026) announced on January 12, 2024. The fiscal 2029 sales target under the long-term management plan was raised from ¥52 billion to ¥55 billion, and ordinary income was increased from ¥6.0 billion to ¥6.8 billion plus α. Additionally, the fiscal 2026 sales target under the second three-year plan was revised upward from ¥48.8 billion to ¥52 billion, and ordinary income was adjusted from ¥5.5 billion to ¥6.1 billion. The targets for ROE, ROIC, and equity ratio remain unchanged.

Reasons for Revision and Future Outlook

The revision reflects growth investments underpinned by increased production capacity, and the strengthening of profit and production bases through three reforms: profit structure reform, manufacturing reform, and work style reform. The pesticide and fine chemical businesses have been performing steadily. There are no changes to growth strategies under the second three-year management plan, and these revised targets are consistent with the consolidated earnings guidance in the financial summary for the fiscal year ending November 2026. It is also noted that future performance may be subject to various influencing factors.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.